Osteoclasts in the Inflammatory Arthritis: Implications for Pathologic Osteolysis
- Author:
Youn Kwan JUNG
1
;
Young Mo KANG
;
Seungwoo HAN
Author Information
- Publication Type:Review
- Keywords: Osteoclasts; Arthritis, rheumatoid; Osteolysis; Osteoimmunology
- MeSH: Adaptive Immunity; Antibodies; Arthritis; Arthritis, Rheumatoid; Calcium Signaling; Cytokines; Gout; Immune System; Inflammasomes; Interleukin-6; Interleukin-8; Leucine; Osteoclasts; Osteolysis; Osteoporosis; T-Lymphocyte Subsets; Vimentin
- From:Immune Network 2019;19(1):e2-
- CountryRepublic of Korea
- Language:English
- Abstract: The enhanced differentiation and activation of osteoclasts (OCs) in the inflammatory arthritis such as rheumatoid arthritis (RA) and gout causes not only local bone erosion, but also systemic osteoporosis, leading to functional disabilities and morbidity. The induction and amplification of NFATc1, a master regulator of OC differentiation, is mainly regulated by receptor activator of NF-κB (RANK) ligand-RANK and calcium signaling which are amplified in the inflammatory milieu, as well as by inflammatory cytokines such as TNFα, IL-1β and IL-6. Moreover, the predominance of CD4+ T cell subsets, which varies depending on the condition of inflammatory diseases, can determine the fate of OC differentiation. Anti-citrullinated peptide antibodies which are critical in the pathogenesis of RA can bind to the citrullinated vimentin on the surface of OC precursors, and in turn promote OC differentiation and function via IL-8. In addition to adaptive immunity, the activation of innate immune system including the nucleotide oligomerization domain leucine rich repeat with a pyrin domain 3 inflammasome and TLRs can regulate OC maturation. The emerging perspectives about the diverse and close interactions between the immune cells and OCs in inflammatory milieu can have a significant impact on the future direction of drug development.
